← Mechanisms of action
Interleukin-23
PROTEIN COMPLEXHomo sapiens
Linked proteins
Drugs acting on this target (8)
| Active Pharmaceutical Ingredient | Mechanism Type ▲ | Approval Status | API Type | Mechanism of Action |
|---|---|---|---|---|
| risankizumab (Skyrizi) | Antagonist | approved | mAb | Interleukin-23 antagonist |
| brazikumab | Inhibitor | experimental | mAb | Interleukin-23 inhibitor |
| briakinumab | Inhibitor | experimental | mAb | Interleukin-23 inhibitor |
| guselkumab (tremfya) | Inhibitor | approved | mAb | Interleukin-23 inhibitor |
| mirikizumab (Omvoh) | Inhibitor | approved | mAb | Interleukin-23 inhibitor |
| risankizumab (Skyrizi) | Inhibitor | approved | mAb | Interleukin-23 inhibitor |
| tildrakizumab (Ilumetri) | Inhibitor | approved | mAb | Interleukin-23 inhibitor |
| ustekinumab (stelara) | Inhibitor | approved | mAb | Interleukin-23 inhibitor |